• Daily News
  • Weekly News
  • Special Editions
  • Oil and Gas Events
  • Key Economic Indicators
  • Other Services
Country List
  • Algeria
  • Bahrain
  • Egypt
  • Iran
  • Iraq
  • Kuwait
  • Libya
  • Oman
  • Qatar
  • Saudi Arabia
  • UAE
  • Yemen
  • General News
PAM
  • Project Activity Monitoring
  • Company Activity Monitoring

For Free Headlines Submit Your Email

Login  

Friday, May 9, 2025 7:32 GMT

  • Home
  • About Us
  • Archive
  • Contact Us

News

Iran-Cuba Vaccine Gets Emergency Use License for 2-18 Ages


Spokesman for Iran’s Food and Drug Administration (FDA) announced that the Iran-Cuba joint vaccine SOBERANA 02 has received an emergency license in Cuba for the age group of 2 to 18 years. The Iran-Cuba joint vaccine Soberana02 vaccine has received an emergency use license in Cuba for the age group of 2 to 18 years, Kianoush Jahanpour wrote in his Twitter account.
 The director of the clinical trial project of the third phase of the Cuban-Iranian joint vaccine had previously noted that the study on the effectiveness of the SOBERANA 02 vaccine has been completed in the six cities. It is worth mentioning that the joint vaccine of Iran and Cuba can be considered as one of the most successful vaccines in the world. - Mehr


published:07/09/2021 04:53 GMT

Related News

  • Cuba Says Iran to Start Producing One of Its COVID-19 Vaccines  01/08/2021 04:31 GMT
  • Iran-Cuba Vaccine 91.2% Effective against Covid-19 Variants  26/07/2021 06:55 GMT

© 2025 BEDigest. All Rights Reserved.

to read more about this project please go to